I received my doctorate in biochemistry at Boston University and my postdoctoral training at the Massachusetts General Hospital, Harvard Medical School. I then accepted a position at the University of Central Florida as an assistant professor at The NanoScience Technology Center (NSTC), eventually becoming an associate professor with tenure. Although initially trained as a biochemist, during my postdoctoral training I developed into a bio-organic and conjugation chemist. I also trained in molecular imaging, particularly the development of iron oxide nanoparticles as MRI probes and nanosensors. My current research interests are the development of novel nanoparticle-based systems that integrate imaging and drug delivery capabilities, molecular imaging, diagnostics and therapeutics for cancer."
- Hyperbranched Polymeric Nanoparticles as Delivery Vehicles for Cancer Therapeutics
- Activatable Molecular Imaging Agents
- Small-Molecule-Based Activatable Prodrug for the Detection and Treatment of Tumors
- Binding Magnetic Relaxation Nanosensors for the Assessment of Molecular Interactions
Kaittanis C, Shaffer TM, Ogirala A, Santra S, Perez JM, Chiosis G, Li Y, Josephson L, Grimm J.
Nature Comm. 2014 Mar 5;5:3384.
Lee MW, Bassiouni R, Sparrow NA, Iketani A, Boohaker RJ, Moskowitz C, Vishnubhotla P, Khaled AS, Oyer J, Copik A, Fernandez-Valle C, Perez JM, Khaled AR.
Cell Death Dis. 2014 May 22;5:e1249.
Santiesteban OJ, Kaittanis C, Perez JM.